Plumbagin shows anti-cancer activity in human breast cancer cells by the upregulation of p53 and p21 and suppression of G1 cell cycle regulators

European Journal of Gynaecological Oncology

Volumn 37, Issue 1, 2016, Pages 30-35

  Zhang, X Q ^a   Yang, C Y ^a   Rao, X F ^a   Xiong, J P ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Cyclin Dl; Cyclin E; MCF 7; P53; Plumbagin; Proliferation

Indexed keywords

CYCLIN D1; CYCLIN E; PLUMBAGIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P21; PROTEIN P53; ANTINEOPLASTIC AGENT; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; NAPHTHOQUINONE; TP53 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MTT ASSAY; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; CELL PROLIFERATION; DRUG EFFECTS; G1 PHASE CELL CYCLE CHECKPOINT; GENETICS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; MCF-7 CELLS; NAPHTHOQUINONES; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84960929004     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: 10.12892/ejgo2765.2016     Document Type: Article

References (37)

1. Angelopoulos N., Barbounis V., Livadas S., Kaltsas D., Tolis G.: "Effects of estrogen deprivation due to breast cancer treatment". Endocr. Relat. Cancer, 2004, 11, 523.
2. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al.: "Cancer Statistics". CA Cancer J. Clin., 2006, 56, 106.
3. Ferguson P. J., Kurowska E., Freeman D. J., Chambers A. F., Koropatnick D. J.: "A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines". J. Nutr:, 2004, 134, 1529.
4. Jo E. H., Hong H. D., Ahn N. C., Jung J. W., Yang S. R., Park J. S., et al.: "Modulations of the Bcl-2/Bax family were involved in the chemopreventive effects of licorice root (Glycyrrhiza uralensis Fisch) in MCF-7 human breast cancer cell". J. Agric. Food Chem, 2004, 52, 1715.
5. Mukherjee A. K., Basu S., Sarkar N., Ghosh A. C.: " Advances in cancer therapy with plant based natural products". Curr: Med. Chem., 2001, 8, 1467.
6. Chen M. S., Chen D., Dou Q. P.: "Inhibition of proteasome activity by various fruits and vegetables is associated with cancer cell death". In Vivo, 2004, 18, 73.
7. Cragg G. M., Newman D. J.: "Plants as a source of anti-cancer agents". J. Ethnopharmacol, 2005, 100, 72.
8. Tan G., Gyllenhaal C., Soejarto D. D.: "Biodiversity as a source of anticancer drugs". Cun: Drug Targets, 2006, 7, 265.
9. Ivanova D., Gerova D., Chervenkov T., Yankov T.: "Polyphenols and antioxidant capacity of Bulgarian medicinal plants". J. Ethnopharmacol, 2005, 96, 145.
10. Samarghandian S., Afshari T. J., Davoodi S.: Suppression of pulmonary tumor promotion and induction of apoptosis by Crocus sativus L. extraction". Appl. Biochem. Biotechnol, 2011, 164, 235.
11. Adamsen B. L., Kravik K. L., Clausen O. P., De Angelis P. M.:" Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to shortterm 5-fluorouracil treatment". Int. J. Oncol., 2007, 31, 1491.
12. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C.: "A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V". J. Immunol. Methods, 1995, 184, 39.
13. Gewirtz D. A., Elmore L. W.: "Apoptosis as the predominant tumor cell response to chemotherapy and irradiation: a case of TUNEL vision?". Curr. Opin. Investig. Drugs, 2005, 6, 1199.
14. Bold R. J., Termuhlen P. M., McConkey D. J.:" Apoptosis, cancer and cancer therapy". Surg. Oncol., 1997, 6, 133.
15. Samarghandian S., Boskabady M. H., Davoodi S.: "Use of in vitro assays to assess the potential antiproliferative and cytotoxic effects of saffron (Crocus sativus L.) in human lung cancer cell line". Pharmacogn. Mag., 2010, 6, 309.
16. Samarghandian S., Afshari J. T., Davoodi S.: "Honey induces apoptosis in renal cell carcinoma". Pharmacogn. Mag, 2011, 7, 46.
17. Bergamaschi G., Rosti B., Danova M., Lucotti C., Cazzola M.: "Apoptosis: biological and clinical aspects". Haemalologica, 1994, 79, 86.
18. Steller H.: "Mechanism and genes of cellular suicide". Science, 1996, 267, 1445.
19. Penninger J. M., Kroemer G.: "Molecular and cellular mechanisms of T lymphocyte apoptosis". Adv. Immunol, 1996, 68, 51.
20. Lowe S. W., Ruley H. E., Jacks T., Housman D. E.: "p53-dependent apoptosis modulates the cytotoxicity of anticancer agents". Cell, 1993, 74, 957.
21. Linke S. P., Clarkin K. C., Wahl G. M.: "p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation". Cancer Res., 1997, 57, 1171.
22. Midgley C. A., Owens B., Briscoe C. V., Thomas D. B., Lane D. P., Hall P. A.: "Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo ". J. Cell. Sci, 1995, 108, 1843.
23. Zhan Q., Alamo I., Yu K.: "The apoptosis-associated gamma-ray response of BCL-XL depends on normal p53 function". Oncogene, 1996, 13, 2287.
24. Padhye S., Dandawate P., Yusufi M., Ahmad A.., Sarkar F. H.: "Perspectives on medicinal properties of plumbagin and its analogs". Med. Res. Rev., 2012, 32, 1131.
25. Xu T. P., Shen H., Liu L. X., Shu Y. Q.: "Asian-Pac. Plumbagin from Plumbago Zeylanica L Induces Apoptosis in Human Non-small Cell Lung Cancer Cell Lines through NFkB Inactivation". J. Cancer Prev., 2013, 14, 2325.
26. Sinha S., Pal K., Elkhanany A., Dutta S., Cao Y., Mondai G., et al.: "Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo ". Int. J. Cancer, 2013, 132, 1201.
27. Hafeez B. B., Zhong W., Fischer J. W., Mustafa A., Shi X., Meske L., et al.: "Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1, 4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model". Mol. Oncol., 2013, 7, 428.
28. Ahmad A., Banerjee S., Wang Z., Kong D., Sarkar F. H.: "Plumbagininduced apoptosis of human breast cells is mediated by inactivation of NF-kappaB and Bcl-2". J. Cell Biochem,. 2008, 105, 1461.
29. Hsu Y. L., Cho C. Y., Kuo P. L., Huang Y. T., Lin C. C.: " Plumbagin (5-hydroxy-2-methy 1-1, 4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun. NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo". J. Pharmacol. Exp. Then, 2006, 318, 484.
30. Hafeez B. B., Zhong W., Mustafa A., Fischer J. W., Witkowsky O., Verma A. K..: "Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCs, Stat3 and neuroendocrine markers". Carcinogenesis, 2012, 33, 2586.
31. Kuo P. L., Hsu Y. L., Cho C. Y.: "Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells". Mol. Cancer Ther., 2006, 5, 3209.
32. Gomathinayagam R., Sowmyalakshmi S., Mardhatillah F., Kumar R., Akbarsha M. A., Damodaran C.: "Anticancer mechanism of Plumbagin, a natural compound, on non-small cells lung cancer cells". Anticancer Res. 2008, 28, 785.
33. Ravindra K. C., Selvi B. R., Arif M., Reddy B. A., Thanuja G. R., Agrawal S., et al.: "Inhibition of lysine acetyltransferase KAT3B/p300 activity by a naturally occurring hydroxynaphthoquinone, plumbagin". J. Biol. Chem., 2009, 284, 24453.
34. Suzuki K., Matsubara H.: "Recent advances in p53 research and cancer treatment". J. Biomed. Biotechnol., 2011, 2011, 978312. doi: 10.1155/2011/978312. Epub 2011 Jun. 16.
35. Christophorou M. A., Ringshausen I., Finch A. J., Swigart L. B., Evan G. I.: "The pathological response to DNA damage does not contribute to p53-mediated tumour suppression". Nature, 2006, 443, 214.
36. Moll U. M., Wolff S., Speidel D., Deppert W.: "Transcription-independent pro-apoptotic functions of p53". Curr. Opin. Cell. Biol., 2005, 17, 631.
37. Slee E. A., O'Connor D. J., Lu X.: "To die or not to die: how does p53 decide?" Oncogene, 2004, 23, 2809.